Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Current Deferred Revenue (2016 - 2026)

Sensus Healthcare has reported Current Deferred Revenue over the past 11 years, most recently at $842000.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 55.64% year-over-year to $842000.0; the TTM value through Dec 2025 reached $842000.0, up 55.64%, while the annual FY2025 figure was $842000.0, 55.64% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $842000.0 at Sensus Healthcare, up from $648000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $1.8 million in Q1 2021 and troughed at $529000.0 in Q2 2025.
  • A 5-year average of $937250.0 and a median of $802500.0 in 2023 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: crashed 51.67% in 2022 and later skyrocketed 55.64% in 2025.
  • Year by year, Current Deferred Revenue stood at $1.4 million in 2021, then crashed by 51.67% to $693000.0 in 2022, then decreased by 5.19% to $657000.0 in 2023, then dropped by 17.66% to $541000.0 in 2024, then soared by 55.64% to $842000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for SRTS at $842000.0 in Q4 2025, $648000.0 in Q3 2025, and $529000.0 in Q2 2025.